Why Does an Aging Smoker’s Lung Develop Idiopathic Pulmonary Fibrosis and Not Chronic Obstructive Pulmonary Disease?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Why Does an Aging Smoker’s Lung Develop Idiopathic Pulmonary Fibrosis and Not Chronic Obstructive Pulmonary Disease?

Published:2019-02 Issue:3 Volume:199 Page:279-285
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Selman Moisés¹^ORCID,Martinez Fernando J.²³,Pardo Annie⁴

Affiliation:

1. Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Mexico City, Mexico

2. Weill Cornell Medicine, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York

3. Deputy Editor, AJRCCM; and

4. Facultad de Ciencias, Universidad Nacional Autónoma de México, Mexico City, Mexico

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201806-1166PP

Reference83 articles.

1. Lung ageing and COPD: is there a role for ageing in abnormal tissue repair?

2. The Pathology of Chronic Obstructive Pulmonary Disease

3. Idiopathic pulmonary fibrosis

4. Idiopathic pulmonary fibrosis

5. Short telomeres are a risk factor for idiopathic pulmonary fibrosis

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational Deconvolution of Cell Type-Specific Gene Expression in COPD and IPF Lungs Reveals Disease Severity Associations;2024-03-27

2. Bibliometric and Visual Analysis of Fibrotic Pulmonary Sarcoidosis;2024-03-08

3. Lung immune signatures define two groups of end-stage IPF patients;Respiratory Research;2023-09-28

4. Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies;Frontiers in Pharmacology;2023-08-07

5. Interstitial lung disease—From pulmonary perspective to pathogenesis, multidisciplinary approach and treatment;International Journal of Rheumatic Diseases;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3